drugset / Trial / NCT05331053

MicroRNA Activation of LOX-1 Mechanisms in Endometriosis

NCT05331053 ↗

Phase 4 Terminated 6 enrolled Penn State University
NaSingle-groupOpen-labelBasic science

Summary

Endometriosis is a disorder that occurs in women. With endometriosis, tissue that should be found in the womb is found in sites outside of the womb. This disorder impairs the function of the cells that line the body's blood vessels (endothelium). The endothelium helps to control blood flow in healthy vessels. Women with this disorder have an increased risk for high blood pressure and high cholesterol. They have a higher risk for cardiovascular disease, too. With this study, we will learn how endometriosis impairs the lining of blood vessels and increases the risk for disease.

Timeline

Start
2018-05-01
Primary completion
2022-06-01
Completion
2024-08-31

Outcome

Outcome not reported

Stopped (Business): “COVID halting human subjects research and preliminary data from this proposal were used to submit an NIH grant. The NIH grant was funded and 3 other protocols were launched.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg Oral

Indications